EFTA02667148.pdf
dataset_11 pdf 373.2 KB • Feb 3, 2026 • 6 pages
From: jeffrey E. <jeevacation@gmail.com>
Sent: Wednesday, December 7, 2016 5:53 PM
To: Donald Rubin
Subject: Re: Placebo effects, EB, etc.
query, why are so many distributions in natur= so consistant and accurate. doesnt it give you pause. = like centrigal
force. not a true force but one we sens=. many distributions could be describeds as pseudo forces pus=ing the tails
toward the mean. . . could gravity be one of t=ese pseudo type forces pushing things towards a distribution.?? *=A0
not as silly a question as it first might appear to be . :)
=div class="gmail_extra">
On Wed, Dec 7, 20=6 at 1:47 PM, Donald Rubin t<mailtc > wrote:
Think so.=C24> Where will you be?
On Dec 7, 2016, at 12:25 PM, jeffrey E. <jeevacation@gmail.comqa» wrote:
ar you around on the weekend in cambridg=.?
On Wed, Dec 7, 2016 at 1:10 PM, Donald Rubin wrote:
OK. I'll get back to you after I make contact with=Adriaan again, and my plans settle a bit.
On Dec 7, 2016, at 10:38 AM, jef=rey E. <jeev=cation@gmail.com <mailto:jeevacation@gmail.com»
wrote:
three w=y skype for 3. and yes 1 face to face
On Wed, Dec 7, 2016 at 11:37 AM, Donal= Rubin ail
wrote:
Different ways to follow up.
1. The next time that we're in the sam= town, we could talk about the statistical ideas
underlying ways to disent=ngle placebo effects from biological effects of drugs and why that*=99s important for FDA
approvals and for prescripts in the docs office 4>=804› different answers, I think.
2. I can =end some recent things on the topic of placebo response, which are still n=t that
wonderfully written.
EFTA_R1_01918781
EFTA02667148
3. If intereste= in exploring investing in EB, I can put you in touch with Adriaan, who Ikes in
Amsterdam.
Are any of these appealing?4>=A0 I prefer 1to 2. I think a face to face version of 3 could be
arr=nged either here or there.
Let me know.
On Dec 7, 2016, at 9:35 AM, jeffr=y E. <jeevac=tion@gmail.com
<mailto:jeevacation@gmail.com> wrote:
I'm always interested in unique idea
On Wed, Dec 7, 2016 at 10:12 AM Donald Rubin
wr=te:
Hello Jef=rey,
I'm gl=d that Martin has put us in touch for a couple of reasons. First, I =hink we
have some mutual interests concerning the complications of doing e=periments with humans, rather than plants or
animals or tires. One c=mplication is noncompliance with the assigned treatment, which we briefly =iscussed at the
dinner, but the more interesting one is the placebo effect= which can be gigantic, for example in "viagra" type studi=s,
which we didn't get around to discussing except indirectly in t=e context of the Emotional Brain (EB) female viagra issue.
More generally, this is rela=ed to FDA standards for approving drugs. A slight
aside: in January=l'm one of three people getting honorary degrees from the Medical =acuity of the University of
Uppsala in Sweden, where one of the others is =obert Califf, the current Commissioner of the FDA (the other is Marcia
McN=tt, the current President of the National Academy of Sciences), so I shoul= get the chance to bend his ear at
various meals (a former commissioner =E2401, under Bush II — was a partial PhD student of mine when he=was getting
his MD at Harvard and his PhD in Econ at MIT, and remains a go=d friend: Mark McClellen, who is interested in this stuff
and remains quit= influential in DC, I think).
But the reason for rambling about the FDA and placebo eff=cts is the following.
This morning I just had an exchange of emails =ith the CEO of EB, whom I've known and worked with for about
three=years, Adriaan Tuiten. He wrote that FDA has agreed with EB'= proposal for more trials, and the EB board of
directors just approved the=issuance of about 12 million Euros in stock to pay for these trials. =Adriaan thinks that they
may have enough connections now, but would you be=interested in participating? I already have some stock, which I
earn=d though consulting. I think EB is interesting but still needs more=wisdom when it comes to their statistics (I've
been to FDA with th=m two or three times, and I think they still need help with some of their =deas e.g., using SNPs). If
interested in tossing some money their wa=, let me know.
In a=y case, I very much enjoyed our last conversations, and I look forward to
=eeing you again, either in Cambridge or in NYC, which I'll probabl= get to in the next couple of weeks.
Best wishes, Don
.=br class="m_6900164931154966066m_-6698346136610420412m_-
1196805788815373=82gmail_msg">
2
EFTA_R1_01918782
EFTA02667149
Donald B. Rubin
John L. Loeb P=ofessor of Statistics
<=1"
On Dec 2, 2016, at 9:41 AM, jeffrey E. <
great
On Fri, Dec 2, 2016 at 9:=0 AM, Donald Rubi
e:
Great, thanks Martin= Sometime when I get to NYC, which I often do to visit
Columbia conn=ctions, I'd like to be in touch, and give Jeffery more lectures in=statistics — I think he has some
potential!
<=r class="m_6900164931154966066m_-6698346136610420412m_-
11968057888153736=2gmail_msg">
Also, Martin, should we try to touch base on Monday?=C24› The rest of the
week is pretty much shot for me with visitors.
Best, Don
3
EFTA_R1_01918783
EFTA02667150
> On Dec 2, =016, at 9:32 AM Nowak Martin A
<mai > wrote:=br class="m
1196805788815373=82gmail_msg">
&=t; Don , Jeffrey
> I wou=d like to put you in direct email contact.
> also cc Lesley.
>m
40=A0 please note
The information contained in this communication is
confid=ntial, may be attorney-client privileged, may
4
EFTA_R1_01918784
EFTA02667151
constitute insi=e information, and is intended only for
the use of the addres=ee. It is the property of
JEE
Unauthorized use, =isclosure or copying of this
communication or any part thereo= is strictly prohibited
and may be unlawful. If you have rece=ved this
communication in error, please notify us immediately=by
return e-mail or by e-mail to jeevacation@gmail.com
<mailto:jeevacatio=@gmail.com> , and
destroy this communication and all copies thereof,
i=cluding all attachments. copyright -all rights reserved
<=div>
=C24, please note
The information containe= in this communication is
confidential, may be attorney-client privileg=d, may
constitute inside information, and is intended only for
the u=e of the addressee. It is the property of
JEE
Unauthorized use, disc=osure or copying of this
communication or any part thereof is strictly =rohibited
and may be unlawful. If you have received this
communicati=n in error, please notify us immediately by
return e-mail or by e-mail =o jeevacation@g=ail.com <mailto:jeevacation@gmail.com> ,
and
destroy this communication and all copies thereof,
=ncluding all attachments. copyright -all rights reserved
</=iv>
40=A0 please note
The information contained in this=communication is
5
EFTA_R1_01918785
EFTA02667152
confidential, may be attorney-client privileged, mayconstitute inside information, and is
intended only for
the use of the=addressee. It is the property of
JEE
Unauthorized use, disclosure or=copying of this
communication or any part thereof is strictly prohibite=
and may be unlawful. If you have received this
communication in err=r, please notify us immediately by
return e-mail or by e-mail to jeevacation@gmail.com<=a>, and
destroy this communication and all copies thereof,
including=all attachments. copyright -all rights reserved
p=ease note
The information contained in this communication is
co=fidential, may be attorney-client privileged, may
constitute inside inf=rmation, and is intended only for
the use of the addressee. It is the p=operty of
JEE
Unauthorized use, disclosure or copying of this
com=unication or any part thereof is strictly prohibited
and may be unlawfu=. If you have received this
communication in error, please notify us im=ediately by
return e-mail or by e-mail to jeevacation@gmail.com <mailto:jeevacation=gmail.com> , and
destroy thi= communication and all copies thereof,
including all attachments. copyr=ght -all rights reserved
6
EFTA_R1_01918786
EFTA02667153
Entities
0 total entities mentioned
No entities found in this document
Document Metadata
- Document ID
- 02e006f0-982b-4c92-950a-3b94f1f5c421
- Storage Key
- dataset_11/EFTA02667148.pdf
- Content Hash
- 8d94beb315b4ed95bcf9caee055febda
- Created
- Feb 3, 2026